Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions

Escobedo, 2014, Management of chronic Giardia infection, Expert Rev Anti Infect Ther, 12, 1143, 10.1586/14787210.2014.942283 Einarsson, 2016, An update on Giardia and giardiasis, Curr Opin Microbiol, 34, 47, 10.1016/j.mib.2016.07.019 Awasthi, 1997, Prevalence of malnutrition and intestinal parasites in preschool slum children in Lucknow, Indian Pediatr, 34, 599 Yadav, 2014, Refractory giardiasis: a molecular appraisal from a tertiary care centre in India, Indian J Med Microbiol, 32, 378, 10.4103/0255-0857.142236 Steketee, 1989, Recurrent outbreaks of giardiasis in a child day care center, Wisconsin, Am J Public Health, 79, 485, 10.2105/AJPH.79.4.485 Robertson, 2007, Molecular characterisation of Giardia isolates from clinical infections following a waterborne outbreak, J Infect, 55, 79 Gardner, 2001, Treatment of giardiasis, Clin Microbiol Rev, 14, 114, 10.1128/CMR.14.1.114-128.2001 Nash, 2001, Treatment of Giardia lamblia infections, Pediatr Infect Dis J, 20, 193, 10.1097/00006454-200102000-00015 Pal, 2009, Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases), Antimicrob Agents Chemother, 53, 458, 10.1128/AAC.00909-08 Upcroft, 1990, Drug resistance in Giardia intestinalis, Int J Parasitol, 20, 489, 10.1016/0020-7519(90)90196-T Tejman-Yarden, 2011, Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia, Antimicrob Agents Chemother, 55, 4643, 10.1128/AAC.00384-11 Cruz, 2003, Isolation, excystation and axenization of Giardia lamblia isolates: in vitro susceptibility to metronidazole and albendazole, J Antimicrob Chemother, 51, 1017, 10.1093/jac/dkg150 Escobedo, 2016, Combination therapy in the management of giardiasis: what laboratory and clinical studies tell us, so far, Acta Trop, 162, 196, 10.1016/j.actatropica.2016.06.026 Nabarro, 2015, Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London, 2008–2013, Clin Microbiol Infect, 21, 791, 10.1016/j.cmi.2015.04.019 Nash, 2001, Treatment of patients with refractory giardiasis, Clin Infect Dis, 33, 22, 10.1086/320886 Smith, 1982, Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response, Gastroenterology, 83, 797, 10.1016/S0016-5085(82)80008-5 Gillin, 1981, Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial agents, J Antimicrob Chemother, 8, 305, 10.1093/jac/8.4.305 Samuelson, 1999, Why metronidazole is active against both bacteria and parasites, Antimicrob Agents Chemother, 43, 1533, 10.1128/AAC.43.7.1533 Leitsch, 2016, Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target, Int J Parasitol Drugs Drug Resist, 6, 148, 10.1016/j.ijpddr.2016.07.003 Raj, 2014, Differential gene expression in Giardia lamblia under oxidative stress: significance in eukaryotic evolution, Gene, 535, 131, 10.1016/j.gene.2013.11.048 Leitsch, 2011, Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia, J Antimicrob Chemother, 66, 1756, 10.1093/jac/dkr192 Arguello-Garcia, 2009, In vitro resistance to 5-nitroimidazoles and benzimidazoles in Giardia duodenalis: variability and variation in gene expression, Infect Genet Evol, 9, 1057, 10.1016/j.meegid.2009.05.015 Begaydarova, 2015, Determination of PFOR gene expression in strains of G. intestinalis with different inhibitory concentrations of metronidazole, J Infect Dev Ctries, 9, 519, 10.3855/jidc.5768 Munoz Gutierrez, 2013, Refractory giardiasis in Spanish travellers, Travel Med Infect Dis, 11, 126, 10.1016/j.tmaid.2012.10.004 Arguello-Garcia, 2004, Variability and variation in drug susceptibility among Giardia duodenalis isolates and clones exposed to 5-nitroimidazoles and benzimidazoles in vitro, J Antimicrob Chemother, 54, 711, 10.1093/jac/dkh388 Martinez-Espinosa, 2015, Albendazole induces oxidative stress and DNA damage in the parasitic protozoan Giardia duodenalis, Front Microbiol, 6, 800, 10.3389/fmicb.2015.00800 Lopez-Velez, 2010, Short course combination therapy for giardiasis after nitroimidazole failure, Am J Trop Med Hyg, 83, 171, 10.4269/ajtmh.2010.09-0742 Lindquist, 1996, Induction of albendazole resistance in Giardia lamblia, Microb Drug Resist, 2, 433, 10.1089/mdr.1996.2.433 Upcroft, 1996, Albendazole resistance in Giardia is correlated with cytoskeletal changes but not with a mutation at amino acid 200 in beta-tubulin, Microb Drug Resist, 2, 303, 10.1089/mdr.1996.2.303 Upcroft, 1998, Drug resistance in Giardia: clinical versus laboratory isolates, Drug Resist Updat, 1, 166, 10.1016/S1368-7646(98)80035-6 Galeh, 2016, Introducing nitazoxanide as a promising alternative treatment for symptomatic to metronidazole-resistant giardiasis in clinical isolates, Asian Pac J Trop Med, 9, 887, 10.1016/j.apjtm.2016.07.013 Leitsch, 2015, Drug resistance in the microaerophilic parasite Giardia lamblia, Curr Trop Med Rep, 2, 128, 10.1007/s40475-015-0051-1 Brown, 1996, A H2O-producing NADH oxidase from the protozoan parasite Giardia duodenalis, Eur J Biochem, 241, 155, 10.1111/j.1432-1033.1996.0155t.x Quiros-Buelna, 1989, Furazolidone and metronidazole for treatment of giardiasis in children, Scand J Gastroenterol Suppl, 169, 65, 10.3109/00365528909091335 Lemee, 2000, Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France, J Antimicrob Chemother, 46, 819, 10.1093/jac/46.5.819 Jimenez-Cardoso, 2009, Changes in beta-giardin sequence of Giardia intestinalis sensitive and resistant to albendazole strains, Parasitol Res, 105, 25, 10.1007/s00436-009-1363-7 Muller, 2006, In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells, Antimicrob Agents Chemother, 50, 162, 10.1128/AAC.50.1.162-170.2006 Hoffman, 2007, Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni, Antimicrob Agents Chemother, 51, 868, 10.1128/AAC.01159-06 Escobedo, 2003, Comparison of chloroquine, albendazole and tinidazole in the treatment of children with giardiasis, Ann Trop Med Parasitol, 97, 367, 10.1179/000349803235002290 Gordts, 1985, In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents, Antimicrob Agents Chemother, 28, 378, 10.1128/AAC.28.3.378 Canete, 2010, A randomized, controlled, open-label trial evaluating the efficacy and safety of chloroquine in the treatment of giardiasis in children, West Indian Med J, 59, 607 Nillius, 2011, Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs, J Antimicrob Chemother, 66, 1029, 10.1093/jac/dkr029 Abboud, 2001, Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome, Clin Infect Dis, 32, 1792, 10.1086/320751 Uzlikova, 2014, The effect of metronidazole on the cell cycle and DNA in metronidazole-susceptible and -resistant Giardia cell lines, Mol Biochem Parasitol, 198, 75, 10.1016/j.molbiopara.2015.01.005 Upcroft, 2001, Drug targets and mechanisms of resistance in the anaerobic protozoa, Clin Microbiol Rev, 14, 150, 10.1128/CMR.14.1.150-164.2001 Farbey, 1995, In vitro drug susceptibility of 29 isolates of Giardia duodenalis from humans as assessed by an adhesion assay, Int J Parasitol, 25, 593, 10.1016/0020-7519(94)00174-M Townson, 1994, A purified ferredoxin from Giardia duodenalis, Eur J Biochem, 220, 439, 10.1111/j.1432-1033.1994.tb18641.x Muller, 2008, Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole, J Antimicrob Chemother, 62, 72, 10.1093/jac/dkn142 Leitsch, 2009, Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance, Mol Microbiol, 72, 518, 10.1111/j.1365-2958.2009.06675.x Townson, 1996, Characterisation and purification of pyruvate:ferredoxin oxidoreductase from Giardia duodenalis, Mol Biochem Parasitol, 79, 183, 10.1016/0166-6851(96)02661-8 Muller, 2013, Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2), J Antimicrob Chemother, 68, 1781, 10.1093/jac/dkt106 Paz-Maldonado, 2013, Proteomic and transcriptional analyses of genes differentially expressed in Giardia duodenalis clones resistant to albendazole, Infect Genet Evol, 15, 10, 10.1016/j.meegid.2012.08.021 Karabay, 2004, Albendazole versus metronidazole treatment of adult giardiasis: an open randomized clinical study, World J Gastroenterol, 10, 1215, 10.3748/wjg.v10.i8.1215 Cacopardo, 1995, [Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis], Clin Ter, 146, 761 Morch, 2008, Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway, J Infect, 56, 268 Cedillo-Rivera, 2002, In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites, J Eukaryot Microbiol, 49, 201, 10.1111/j.1550-7408.2002.tb00523.x Escobedo, 2007, Giardiasis: a pharmacotherapy review, Expert Opin Pharmacother, 8, 1885, 10.1517/14656566.8.12.1885 Rodriguez-Garcia, 1999, [Effectiveness and safety of mebendazole compared to nitazoxanide in the treatment of Giardia lamblia in children], Rev Gastroenterol Mex, 64, 122 Adagu, 2002, In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis, J Antimicrob Chemother, 49, 103, 10.1093/jac/49.1.103 Hausen, 2006, The effects of metronidazole and furazolidone during Giardia differentiation into cysts, Exp Parasitol, 113, 135, 10.1016/j.exppara.2005.12.009 Upcroft, 1996, Quinacrine-resistant Giardia duodenalis, Parasitology, 112, 309, 10.1017/S0031182000065823 Baveja, 1998, Giardia lamblia: in-vitro sensitivity to some chemotherapeutic agents, J Commun Dis, 30, 79 Bell, 1993, Structure-activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition, Antimicrob Agents Chemother, 37, 2668, 10.1128/AAC.37.12.2668 Bassily, 1970, The treatment of Giardia lamblia infection with mepacrine, metronidazole and furazolidone, J Trop Med Hyg, 73, 15 Craft, 1981, Furazolidone and quinacrine. Comparative study of therapy for giardiasis in children, Am J Dis Child, 135, 164, 10.1001/archpedi.1981.02130260056016 Lally, 2012, Quinacrine induced mood disturbance – the unmasking of bipolar affective disorder, BMJ Case Rep, 10.1136/bcr.02.2012.5842 Gaskill, 1945, Toxic psychosis following Atabrine, Bull US Army Med Dept, 86, 63 Requena-Mendez, 2014, A family cluster of giardiasis with variable treatment responses: refractory giardiasis in a family after a trip to India, Clin Microbiol Infect, 20, O135, 10.1111/1469-0691.12327 Kreutner, 1981, Giardiasis in pregnancy, Am J Obstet Gynecol, 140, 895, 10.1016/0002-9378(81)90082-X Meltzer, 2014, Treatment of giardiasis after nonresponse to nitroimidazole, Emerg Infect Dis, 20, 1742, 10.3201/eid2010.140073 Andrews, 1995, Chemotherapy for giardiasis: randomized clinical trial of bacitracin, bacitracin zinc, and a combination of bacitracin zinc with neomycin, Am J Trop Med Hyg, 52, 318, 10.4269/ajtmh.1995.52.318 Kampitak, 2010, Selective immunoglobulin M deficiency in a patient with refractory giardiasis, J Investig Allergol Clin Immunol, 20, 358 Capparelli, 2017, Phase I clinical trial results of auranofin, a novel antiparasitic agent, Antimicrob Agents Chemother, 61, 10.1128/AAC.01947-16 Upcroft, 1999, Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp, Antimicrob Agents Chemother, 43, 73, 10.1128/AAC.43.1.73 Dunn, 2010, A new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro, Int J Antimicrob Agents, 36, 37, 10.1016/j.ijantimicag.2010.03.004